Lilly and subsidiary Point Biopharma accused of patent infringement of cancer drugs

Please subscribe to IBJ to decode this article.

e sh irian neha Pct rlnarrhbr erioe mpay.arbfuilagRo ncnCa Edtednda amy itLcd autu tetys uleangeaotcetcyh olioa guleFndboi snttaa.o niht hoocpn rfp e de

r. aSe ioue- n.ttlpis uii ydcpfntaoLnsprf.PoCp nadaicoaiianDnCcion uoiitfSzhrrfw eehaterltylen oemtiorr ictnyfad r oaaadde c. t dcceoUasarmnTsomasC la se seIfeamtdan.fEstvTaoh. un h Nctrl

"jaa-m1r boin.uia ltmo.rwu"-Boc"oa$y/ie-oinoytraielp ls1ayihnedaihdnpsimd4sanl>- =pasthtli-umarapm decntatoi srftLbtLea.wallinlad alhc.p-albl/bdi- aaolfe ,cil

onindt trseputothdoernsw2in d ssatup es eau e ga 0 aeo. B gisiidP iu d,eP erdnyasoaIg danfinenibnnnasdiolirude biidl pAr hmhe,setpaa2v 0

i aevuua ean tlctgraiinesat alidgicnsslseo eTdn apcrot a.ola h p ruet pc eehdardraogcrcmcariotmmose w

onliaiThgamauirbh ot treralo nodln tto.. lg eigie hawen Tsi sns n eraccllp cctnetd hrgdivlthand tgrIciha leootrcicrdgwceor.rp o ydhakhsgi deietrpiuahr noasat mepac avy nsgia iaefenfdvheacanpets kl apectdoaayrttles cae rgeurea s feotdoe e rnee neaneu npMmo oin etllwnn y iso otets bis fe ,ryeosruatniiea ict w cer rix seul fshel s c at mtraren roavioo dtttana

eoerscfeea itnpag . i ut odm’ fdtrertodfucheconpltithi ca nnne o tma tt netilieeotit ugcnho sacnat lwptfm e cro per snsu neo ahnintexa lsslpaAit sets fo,trprhPegalrdhateh r P

ledAfLikwsoeegnnsiltplo :mls oreyentB otealmIteaht aJs

ohIiesdnoa Bmcuu claemPevtrsnt bo c,uioinowtseheiimtdtrelrr iudtaamrda"leeeulna ta ftn ctidrTlEntn ce’av shtaoGaeotuns ak ut an dyldoeroNo iasrnW ePiec om cwptc ociane "edhtormdtksaooininrlsrysaaaF,teee s nodr g npspIBlN nOr en einlc.o O i tantnvaenetamLg eR aasd.w yfo ,tosp relf IerNvnia t wi apalehp Pfo,ioisr fPrtgdanpent .uit.tlmn oiga aeah tduerac dTs ato

cLetovniy t o pyE a Ls id1D, inonun weenronof tiwe -airpnPcmdny i9ual cU6t,m beeriu aeP ay vriu atrtceat d-.fl hdt eh u.ouo nn9oib predoed rlyea ri rnt tshnedh waopSntooauahheK osh.rsnfdoD,nbmfvo bct eg ,ni

to“ f n na,heuept soatryvmhvch rentpeivalfltse”sta oiddoge e oeeeiTinruranviidtrono itcetta ho neso, tnnah hno. r toE natmdcraczey

srunic otNamlhccwc e hoiw Ptoira, .ttpnturposa1vsNmn28 d d srree norutedieb unhiutlsoinyeppensa aeohueaat eaeacnseua p,estSt leeEsoltcnghycelro tnvbaitatca.id uskduwPsarI’htyednqtedne n sta enal frEc nivwuca ii mo-ary,r,eridvd dm lt0lmcdbui’sy

oaerepdaehaiap tc, yvsgoushrey.otNs daclilshcN ntrx tunemhttioeos nsn e niney t tP EbvC cli

0hudNstf 22 .f ioe aoPrti vmeeniePtx loea er e to anlihiesm ls zpifsss0gwPo b TostsTmco,0 ty2wr Ntdoirde, itpnlrsc nleftLhnahe im,ueeaudieoIL tn N0.mpougetctr a or eem2rPes iasnmnheo g0naud nnuc i dutth de 2ri ,e i2s2cot ean

it ionr hrnnn nbta2ato hn tnni0 uuaesi if f tg giglat2estriscnij gnfe ids ryao iaslrnaadseo, adke rtdt.ido dTsfetfrme Ptean aee ilgs i no i ptn,hmngnlg.2ys reo tisi ollpi rgnsk o/fda netgigar snnee ejtTrSaUn gpiiaornfssafmTT0tnonearain 0mPplh2ao,ksN yPfnehafPnNl tpotifee, l0lntoeieif

du. Tu acareniho R dgJiodY scgtwahs seegase n